HUTCHMED (China) (HCM) Cash from Operations (2018 - 2021)
HUTCHMED (China) (HCM) posted quarterly Cash from Operations of 93675000.0 for Q2 2021, up 210.87% year-over-year from 30133000.0 in Q2 2020, and up 519.02% quarter-over-quarter from 22356000.0 in Q1 2021.
HUTCHMED (China) (HCM) Cash from Operations (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Cash from Operations for 4 consecutive years, with 93675000.0 the latest figure, recorded in Q2 2021.
- In Q2 2021, Cash from Operations rose 210.87% year-over-year to 93675000.0; the TTM figure through Jun 2021 stood at 99695000.0 (up 220.72% YoY), while the FY2025 annual figure was 8318900.5, down 13081.97% from the prior year.
- Cash from Operations climbed to 93675000.0 in Q2 2021 per HCM's latest filing, from 22356000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 93675000.0 in Q2 2021 and bottomed at 144438000.0 in Q4 2019.
- Historically, Cash from Operations has averaged 4302500.0 across 4 years, with a median of 7529000.0 in 2018.
- Annual changes were most pronounced in 2019 — Cash from Operations surged 10528.89% — and 2021, when it tumbled 1172.4%.
- HUTCHMED (China)'s Cash from Operations stood at 13936000.0 in 2018, then tumbled by 1136.44% to 144438000.0 in 2019, then surged by 120.86% to 30133000.0 in 2020, then surged by 210.87% to 93675000.0 in 2021.
- Business Quant data shows HCM's Cash from Operations at 93675000.0 in Q2 2021, 22356000.0 in Q1 2021, and 30133000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | HUTCHMED (China) | 2.17 Bn | 2.17 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 93.68 Mn |
| Jun 30, 2021 | 93.68 Mn |
| Mar 31, 2021 | -22.36 Mn |
| Mar 31, 2021 | -22.36 Mn |
| Jun 30, 2020 | 30.13 Mn |
| Jun 30, 2020 | 30.13 Mn |
| Mar 31, 2020 | -1.76 Mn |
| Mar 31, 2020 | -1.76 Mn |
| Dec 31, 2019 | -144.44 Mn |
| Dec 31, 2019 | -144.44 Mn |
| Sep 30, 2019 | 33.48 Mn |
| Sep 30, 2019 | 33.48 Mn |
| Jun 30, 2019 | 1.12 Mn |
| Jun 30, 2019 | 1.12 Mn |
| Mar 31, 2019 | 28.92 Mn |
| Mar 31, 2019 | 28.92 Mn |
| Dec 31, 2018 | 13.94 Mn |
| Dec 31, 2018 | 13.94 Mn |
| Sep 30, 2018 | 315,000.00 |
| Sep 30, 2018 | 315,000.00 |